Omotesando Helene Clinic Participates in Regenerative Medicine Joint Project in Indonesia as Tokyo Clinical Base for HELENE BIO Group

Omotesando Helene Clinic (located in Minato Ward, Tokyo; hereinafter "Omotesando Helene Clinic") is participating in a joint regenerative medicine project in Indonesia as the Tokyo clinical base for the HELENE BIO Group, which operates in the fields of regenerative medicine, advanced cell therapy, and ATMP (Advanced Therapy Medicinal Products).

In connection with this, the HELENE BIO Group signed a Memorandum of Understanding (MOU) on April 27, 2026, with PT Star Health Indonesia (located in Banten Province, Indonesia; hereinafter "Star Health Indonesia"), which operates the StarCare International Clinic in Indonesia, to explore a joint project for establishing a stem cell clinic and cell processing facility in the country.

Under this MOU, both parties plan to discuss the development of clinical facilities for regenerative medicine and a laboratory environment capable of handling cell processing, quality control, storage, and traceability, based at Star Health Indonesia's facilities within the BSD City Special Economic Zone (Kawasan Ekonomi Khusus, hereinafter "KEK") in Banten Province, Indonesia.

This project will explore the feasibility of business commercialization, including the potential for treatments using autologous and allogeneic mesenchymal stem cells (MSCs), in accordance with relevant Indonesian laws, permits, medical ethics, professional regulations, quality standards, as well as requirements for patient consent and data protection.

The commencement of actual medical services and cell processing operations is contingent upon obtaining all necessary permits and meeting requirements for facilities, personnel, quality management systems, and operational readiness.

The HELENE BIO Group is a global network that comprehensively deploys clinical infrastructure, cell processing and manufacturing, quality control, data utilization, cell banking, and international medical collaboration in the fields of regenerative medicine, advanced cell therapy, and ATMP. While respecting the laws, regulations, and medical systems of each region, the group aims to translate insights accumulated in clinical settings into the development of standardized cell therapies and ATMPs, and to improve international medical access.

In recent years, interest in high-level medical care and the wellness sector in Asia has been rising. In Indonesia, there is an expanding need for high-quality medical services, advanced treatment options, and medical infrastructure that meets international standards. As the Tokyo clinical base for the HELENE BIO Group, Omotesando Helene Clinic aims to build a regenerative medicine platform that prioritizes safety, quality, and ethics by connecting the knowledge in regenerative medicine and cell processing accumulated by the clinic with the local medical infrastructure in Indonesia.